Sorry, page not found…

The Money Morning Web Team works very diligently to minimize "file not found" errors. However in many cases they are unavoidable. You may wish to inform the webmaster of the site: Webmaster E-mail link that this link is outdated.

In the mean time please feel free to search for your article using the search box below or check out some of our most recent analysis.

Search box:

  • Don't Mistake Canoo Stock's "Bump" for a "Rally"

    The electric vehicle (EV) market is witnessing a volatile period, with Canoo (GOEV) recently experiencing a dramatic surge in its stock price. This surge comes on the heels of the U.S. Department of Commerce's decision to approve Canoo's Oklahoma City facility as a foreign trade zone, a move that promises to cut costs and potentially […]

    Learn More
  • The Airlines Are in Trouble

    A good investing friend of mine told me to “never own the airlines, only trade them.” Well, it looks as though the airlines are preparing to give the bears one heck of a good trade. Last year felt like it was the “Year of Weather” delays and cancellations. Every weekend we read about how the […]

    Learn More
  • A Brisk Walk Down Main Street – Airbnb Primer

    I’ve already mentioned the importance of the housing numbers being released on Tuesday, but the data reminded me of another trend in the market, one that could become a long-term headache for Airbnb (ABNB). If you’re not familiar with it, my “Walk Down Main Street” is an approach I use to see investing trends that […]

    Learn More
  • Three Stocks: Tesla, Alphabet, and Super Micro Computer

    Tesla  The Biden Administration can’t make up its mind… Just one month ago to the day (February 18), we saw headlines that the Biden Administration was considering delaying the switch to electric vehicles. The move was partially seen as political to allay fears the Detroit automakers and the unions were having. A month later, and […]

    Learn More
  • The Fed May Break the Market Next Week

    I know, what about the Federal Reserve? We talked about this in Wednesday’s email, but I figured that I should take an extra minute or two of our time to give some detail. SO, Jerome Powell and his band of merry Fed Governors will get together next Wednesday to announce their decision on interest rates. […]

    Learn More
  • Three Stocks: Adobe, SoundHound AI, and Fisker

    Adobe Adobe (ADBE) stock is trading 13% lower at $500 this morning after the company forecasted lighter than expected revenue for the current quarter. The company’s earnings report for last quarter beat expectations, but the market is always forward-looking, so the stock pays today. This is still one of the leaders in generative AI, remember […]

    Learn More
  • Avoid Wall Street’s “Favorite Stock” At All Costs

    It might be the same for you… But when digesting financial news, it can take me two or three reads to get through because of how astounding Wall Street is sometimes. Case in point, their “favorite” stock right now. You’d think it was Nvidia (NVDA). Maybe Microsoft (MSFT). I’d even put Meta (META) in the […]

    Learn More
  • Three Stocks: SoundHound AI, Marathon Digital, and Adobe

    SoundHound AI They’re on the move again!  SoundHound (SOUN) shares are doing exactly what was expected after yesterday’s breakthrough $8, as it rallies another 5% this morning to challenge $10. Let’s take a moment to remember why this company made it on everyone’s radar… SoundHound is a voice recognition company that had originally worked with […]

    Learn More
  • IBM Gets Ready for its Next Breakaway Rally

    I love this situation. An AI stock that the market doesn’t pay attention to is getting ready to break to new all-time highs. It’s not Nvidia (NVDA) or Super Micro Computer (SMCI) or Amazon (AMZN) – it’s lowly, old International Business Machines, A.K.A IBM. A few months ago, we talked about IBM’s bullish trend as […]

    Learn More
  • Three Stocks: MindMed, Tesla, and Dollar Tree

    Mind Medicine What a ride it has been for Mind Medicine (MNMD) investors. We saw the stock shoot through the sky last week on news that the FDA had granted “Breakthrough Therapy Designation” to one of the company’s trial treatments, but then shares dropped 30% from their highs. The pullback is considered healthy at this […]

    Learn More